Transgene Biotek Ltd
BSE:526139
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
5.84
11.98
|
Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one TRABI stock under the Base Case scenario is 0.28 INR. Compared to the current market price of 6.4 INR, Transgene Biotek Ltd is Overvalued by 96%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Transgene Biotek Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for TRABI cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Transgene Biotek Ltd
Balance Sheet Decomposition
Transgene Biotek Ltd
Current Assets | 11.1m |
Cash & Short-Term Investments | 77k |
Receivables | 84k |
Other Current Assets | 10.9m |
Non-Current Assets | 1.4B |
Long-Term Investments | 950k |
PP&E | 16.7m |
Intangibles | 65.5m |
Other Non-Current Assets | 1.3B |
Current Liabilities | 111.4m |
Accounts Payable | 2m |
Short-Term Debt | 89.2m |
Other Current Liabilities | 20.2m |
Non-Current Liabilities | 1.2B |
Long-Term Debt | 50.8m |
Other Non-Current Liabilities | 1.2B |
Earnings Waterfall
Transgene Biotek Ltd
Revenue
|
1.8m
INR
|
Cost of Revenue
|
-5.4k
INR
|
Gross Profit
|
1.8m
INR
|
Operating Expenses
|
-11.8m
INR
|
Operating Income
|
-10m
INR
|
Other Expenses
|
6.8m
INR
|
Net Income
|
-3.2m
INR
|
Free Cash Flow Analysis
Transgene Biotek Ltd
INR | |
Free Cash Flow | INR |
TRABI Profitability Score
Profitability Due Diligence
Transgene Biotek Ltd's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
Score
Transgene Biotek Ltd's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
TRABI Solvency Score
Solvency Due Diligence
Transgene Biotek Ltd's solvency score is 26/100. The higher the solvency score, the more solvent the company is.
Score
Transgene Biotek Ltd's solvency score is 26/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
TRABI Price Targets Summary
Transgene Biotek Ltd
Dividends
Current shareholder yield for TRABI is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Transgene Biotek Ltd. is a biotechnology company, which manufactures and sells diagnostic kits. The company is headquartered in Medak, Telangana. The firm is engaged in a single business segment of Bulk Drugs. Its portfolio of products includes oncology, auto-immunity, drug delivery and biogenerics. The firm offers TrabiAAV, which is a platform for the delivery of micro ribonucleic acids (miRNAs), short hairpin RNA (ShRNAs), immunogens developing clinical significance in gene therapy. The company also offers monoclonal antibody therapy is the use of monoclonal antibodies to specifically bind to target cells. Its TrabiORAL focused on delivering proteins and peptides orally for a variety of human diseases. Its TBL-0404, is used for the treatment of metastatic liver cancer. Its TBL-1203, is used to strengthen cell-mediated immunity and complete elimination of the human immunodeficiency virus (HIV), without any need for retroviral drug therapy. Its Tacrolimus is a drug that suppresses the immune system and is mainly used to prevent rejection of transplanted organs.
Contact
IPO
Employees
Officers
The intrinsic value of one TRABI stock under the Base Case scenario is 0.28 INR.
Compared to the current market price of 6.4 INR, Transgene Biotek Ltd is Overvalued by 96%.